Search

Stephen L. Rawlings

Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )

Most Active Art Unit
1643
Art Unit(s)
1642, 1643, 1646
Total Applications
1483
Issued Applications
633
Pending Applications
153
Abandoned Applications
701

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6304336 [patent_doc_number] => 20100068717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'CANCER THERAPY PROGNOSIS' [patent_app_type] => utility [patent_app_number] => 12/524845 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11004 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068717.pdf [firstpage_image] =>[orig_patent_app_number] => 12524845 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/524845
CANCER THERAPY PROGNOSIS Jan 29, 2008 Abandoned
Array ( [id] => 6220629 [patent_doc_number] => 20100055724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'METHODS OF DETECTING AUTOANTIBODIES FOR DIAGNOSING AND CHARACTERIZING DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/524398 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16742 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055724.pdf [firstpage_image] =>[orig_patent_app_number] => 12524398 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/524398
METHODS OF DETECTING AUTOANTIBODIES FOR DIAGNOSING AND CHARACTERIZING DISORDERS Jan 27, 2008 Abandoned
Array ( [id] => 4778783 [patent_doc_number] => 20080286781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer' [patent_app_type] => utility [patent_app_number] => 12/011459 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 41242 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286781.pdf [firstpage_image] =>[orig_patent_app_number] => 12011459 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/011459
Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer Jan 23, 2008 Abandoned
Array ( [id] => 6430972 [patent_doc_number] => 20100143358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Use of Antibody Conjugates' [patent_app_type] => utility [patent_app_number] => 12/523438 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10269 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143358.pdf [firstpage_image] =>[orig_patent_app_number] => 12523438 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/523438
Use of Antibody Conjugates Jan 21, 2008 Abandoned
Array ( [id] => 5367859 [patent_doc_number] => 20090305418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'CELL THERAPY METHOD FOR THE TREATMENT OF TUMORS' [patent_app_type] => utility [patent_app_number] => 12/014863 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 14700 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305418.pdf [firstpage_image] =>[orig_patent_app_number] => 12014863 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/014863
Cell therapy method for the treatment of tumors Jan 15, 2008 Issued
Array ( [id] => 5348851 [patent_doc_number] => 20090004212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Tumour vaccines for MUC1-positive carcinomas' [patent_app_type] => utility [patent_app_number] => 12/008733 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8292 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004212.pdf [firstpage_image] =>[orig_patent_app_number] => 12008733 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/008733
Tumour vaccines for MUC1-positive carcinomas Jan 13, 2008 Abandoned
Array ( [id] => 4786147 [patent_doc_number] => 20080139476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'CASPASE-8 INTERACTING PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/970986 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26461 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139476.pdf [firstpage_image] =>[orig_patent_app_number] => 11970986 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/970986
CASPASE-8 INTERACTING PROTEINS Jan 7, 2008 Abandoned
Array ( [id] => 4759924 [patent_doc_number] => 20080312150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Treatment and analysis of proliferative disorders' [patent_app_type] => utility [patent_app_number] => 12/005171 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9230 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312150.pdf [firstpage_image] =>[orig_patent_app_number] => 12005171 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/005171
Treatment and analysis of proliferative disorders Dec 20, 2007 Abandoned
Array ( [id] => 6237437 [patent_doc_number] => 20100267933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'PURIFICATION OF PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/448004 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16000 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267933.pdf [firstpage_image] =>[orig_patent_app_number] => 12448004 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/448004
PURIFICATION OF PROTEINS Dec 19, 2007 Abandoned
Array ( [id] => 4778782 [patent_doc_number] => 20080286780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers' [patent_app_type] => utility [patent_app_number] => 12/002783 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34680 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286780.pdf [firstpage_image] =>[orig_patent_app_number] => 12002783 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/002783
Compositions and methods for the identification, assessment, prevention and therapy of human cancers Dec 16, 2007 Issued
Array ( [id] => 4820367 [patent_doc_number] => 20080226621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND TREATMENT OF NOTCH3-RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 11/958099 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 29568 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226621.pdf [firstpage_image] =>[orig_patent_app_number] => 11958099 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/958099
Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases Dec 16, 2007 Issued
Array ( [id] => 4765835 [patent_doc_number] => 20080177047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Single-chain Antibodies Against Human Insulin-Like Growth Factor I Receptor: Expression, Purification, and Effect on Tumor Growth' [patent_app_type] => utility [patent_app_number] => 11/957899 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4253 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177047.pdf [firstpage_image] =>[orig_patent_app_number] => 11957899 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/957899
Single-chain Antibodies Against Human Insulin-Like Growth Factor I Receptor: Expression, Purification, and Effect on Tumor Growth Dec 16, 2007 Abandoned
Array ( [id] => 4595451 [patent_doc_number] => 07981610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)' [patent_app_type] => utility [patent_app_number] => 11/955322 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24619 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981610.pdf [firstpage_image] =>[orig_patent_app_number] => 11955322 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/955322
ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) Dec 11, 2007 Issued
Array ( [id] => 4764630 [patent_doc_number] => 20080175841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Antagonistic Anti-hTNFSF13b Human Antibodies' [patent_app_type] => utility [patent_app_number] => 11/952363 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12914 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175841.pdf [firstpage_image] =>[orig_patent_app_number] => 11952363 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/952363
Antagonistic anti-hTNFSF13b human antibodies Dec 6, 2007 Issued
Array ( [id] => 5970978 [patent_doc_number] => 20110151579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Secreted Epithelial Stromal-1 Molecules and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/951797 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 34516 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20110151579.pdf [firstpage_image] =>[orig_patent_app_number] => 11951797 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/951797
Secreted Epithelial Stromal-1 Molecules and Uses Thereof Dec 5, 2007 Abandoned
Array ( [id] => 4955377 [patent_doc_number] => 20080188401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/948659 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41493 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188401.pdf [firstpage_image] =>[orig_patent_app_number] => 11948659 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/948659
Anti-human IL-6 antibodies Nov 29, 2007 Issued
Array ( [id] => 4786146 [patent_doc_number] => 20080139475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'INHIBITION OF ATF2 ACTIVITY TO TREAT CANCER' [patent_app_type] => utility [patent_app_number] => 11/945133 [patent_app_country] => US [patent_app_date] => 2007-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28750 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139475.pdf [firstpage_image] =>[orig_patent_app_number] => 11945133 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/945133
Inhibition of ATF2 activity to treat cancer Nov 25, 2007 Issued
Array ( [id] => 10018492 [patent_doc_number] => 09060961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Molecules and methods for treatment and detection of cancer' [patent_app_type] => utility [patent_app_number] => 12/446953 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 59 [patent_no_of_words] => 28929 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446953 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/446953
Molecules and methods for treatment and detection of cancer Nov 8, 2007 Issued
Array ( [id] => 4778286 [patent_doc_number] => 20080286284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Compositions of PSMA antibodies' [patent_app_type] => utility [patent_app_number] => 11/983372 [patent_app_country] => US [patent_app_date] => 2007-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 37928 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286284.pdf [firstpage_image] =>[orig_patent_app_number] => 11983372 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/983372
Compositions of PSMA antibodies Nov 6, 2007 Issued
Array ( [id] => 5928897 [patent_doc_number] => 20110038856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/513313 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 31680 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038856.pdf [firstpage_image] =>[orig_patent_app_number] => 12513313 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/513313
METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES Nov 1, 2007 Abandoned
Menu